Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hongchang Fu
Observed names:
Fu, Hongchang,
H. Fu
Institutions:
Royal Marsden NHS Foundation Trust,
The Francis Crick Institute,
Royal Marsden Hospital,
Cancer Research UK Manchester Institute,
Cancer Research UK Manchester Centre,
University College London
show all 6
Observed institutions:
Royal Marsden NHS Foundation Trust,
The Francis Crick Institute,
Royal Marsden Hospital,
Cancer Research UK Manchester Institute,
Cancer Research UK Manchester Centre,
University College London
show all 6
ORCID:
0009-0003-6582-8554
Observed ORCID:
0009-0003-6582-8554
OpenAlex ID:
A5049161563
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
2022
·
Yin Wu
, Dhruva Biswas
, et al.
·
Nature Cancer
·
118
PDF
Using DNA sequencing data to quantify T cell fraction and therapy response
2021
·
Robert Bentham
, Kevin Litchfield
, et al.
·
Nature
·
62
The roles of small RNAs: insights from bacterial quorum sensing
2019
·
Hongchang Fu
, Rosalía Cardós Elena
, et al.
·
ExRNA
·
14
PDF
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidome
2026
·
Roberto Vendramin
, Hongchang Fu
, et al.
·
Immunity
·
9
156O Pharmacologic inhibition of nonsense-mediated decay induces anti-tumour immunogenicity in ex vivo patient tumours
2024
·
Roberto Vendramin
, Hongchang Fu
, et al.
·
ESMO Open
·
4
PDF
Abstract 6737: Pharmacologic modulation of nonsense-mediated decay induces anti-tumor immunogenicity in ex vivo patient tumors
2024
·
Roberto Vendramin
, Hongchang Fu
, et al.
·
Cancer Research
·
2
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation
2026
·
Marcellus Augustine
, Nuno Rocha Nene
, et al.
·
Nature Machine Intelligence
·
1
Distinct functions of PBRM1 and BAP1 reconcile the course of kidney cancer evolution and disease progression
2026
·
Daqi Deng
, Hugang Feng
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 6742: Nonsense-mediated mRNA decay inhibition augments in vitro, in vivo , and ex vivo anti-tumor immunity
2026
·
Hongchang Fu
, Roberto Vendramin
, et al.
·
Cancer Research
266P Disruption of nonsense-mediated mRNA decay enhances anti-tumour immunity
2025
·
R. Vendramin
, H. Fu
·
Immuno-Oncology Technology
PDF
Next generation ex vivo patient-derived tumour explant model for immunotherapy
2025
·
Fu, Hongchang
·
UCL Discovery (University College London)
Abstract 6090: Integration of innate and adaptive immune signatures for early detection of cancer
2024
·
Evelyn Fitzsimons
, Alexander Coulton
, et al.
·
Cancer Research
1O Uncovering new immunotherapy targets with machine learning and ex vivo validation
2024
·
M. Augustine
, N. Rocha Nene
, et al.
·
ESMO Open
PDF
Cancer Associated Bacteria in Primary and Metastatic Non-Small Cell Lung Cancer
2024
·
Krupa Thakkar
, Corentin Richard
, et al.
·
SSRN Electronic Journal
Abstract 3043: Exploring the microbial landscape of NSCLC through TRACERx
2022
·
Krupa Thakkar
, Hongchang Fu
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
210
H-index:
4
I10-index:
3
Year
Topic
Type
